Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type(Echinocandins, Azoles, Ployenes, Allylamines), By Therapeutic Indication(Aspergillosis, Dermatophytosis, Candidiasis, and Others), By Application(Powders, Ointments, Drugs, and Pastes), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35J2113 | Region: Global | Published Date: May, 2024
Pages: 219 |Tables: 94 |Figures: 76

Antifungal Agents Market Insights

Global Antifungal Agents Market size was valued at USD 14.4 billion in 2022 and is poised to grow from USD 14.98 billion in 2023 to USD 20.5 billion by 2031, growing at a CAGR of 4% in the forecast period (2024-2031).

Antifungal agents are drugs that selectively eliminate fungal pathogens from host with minimal toxicity. Growing incidence of fungal infections and rising demand for fungal infection medications are projected to bolster the demand for antifungal agents across the forecast period. Advancements in antifungal drug discovery and development processes are also forecasted to augment antifungal agents market growth trajectory over the coming years. High investments in antifungal drug research are also a key factor that will bolster the sales of antifungal agents in the future. Underdeveloped and developing countries will be highly lucrative markets for antifungal agent providers going forward. On the contrary, antifungal resistance and limited spectrum of antifungal agents are projected to be key restraints for antifungal agents market development in the long run.

Market Snapshot - 2024-2031

Global Market Size

USD 14.4 billion

Largest Segment

Azoles

Fastest Growth

Echinocandins

Growth Rate

4% CAGR

Global Antifungal Agents Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Antifungal Agents Market Segmental Analysis

The global antifungal agents market is segmented based on drug type, application, therapeutic condition, and region. In terms of drug type, the market is bifurcated into echinocandins, azoles, ployenes, allylamines, and others. Based on application, the market is divided into powders, ointments, drugs, and pastes. In terms of therapeutic condition, the market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. Based on region, the market is segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa.

Analysis by Drug Type

Azoles are projected to emerge as the dominating segment in the global antifungal agents market. The use of azoles to treat a wide variety of fungal infections is what allows this segment to account for a high market share. Fewer side effects and enhanced absorption are also key benefits that promote the use of azoles and help its dominance.

Demand for echinocandins is estimated to rise at a rapid pace over the coming years as incidence of complex fungal infections increases. Growing use of echinocandins for treatment of complex fungal infections is projected to boost market growth in the future.

Global Antifungal Agents Market By Drug Type

To get detailed analysis on other segments, Request For Free Sample Report

Antifungal Agents Market Regional Insights

North America is estimated to account for a substantial share of the global antifungal agents market owing to rising cases of fungal infections in this region. of a developed healthcare infrastructure and growing investments in the R&D of novel antifungal drugs and medications are also contributing to the dominance of this segment over the coming years. Increasing cases of antifungal resistance in this region will also boost market growth going forward. The United States is forecasted to spearhead the demand for antifungal agents in the long run.

Meanwhile, the demand for antifungal agents in the Asia Pacific region is slated to rise at a rapid pace over the coming years. Rising awareness regarding fungal infections, high investments in healthcare infrastructure development, and growing availability of novel antifungal agents are all helping this region to maintain its fastest-growing stance in the global landscape. China, India, Indonesia, and Japan are slated to be the most lucrative markets for antifungal agent providers in the Asia Pacific region.

Global Antifungal Agents Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Antifungal Agents Market Dynamics

Drivers

High Prevalence of Fungal Infections

  • Widespread antibiotic resistance and growing incidence of infectious chronic diseases are key factors responsible for increasing fungal infections among patients, which in turn, is projected to boost antifungal agent demand outlook.

Advancements in Antifungal Drug Development

  • High investments in medical and pharmaceutical R&D have led to significant advancements in antifungal drug development. These advancements are estimated to favor sales of antifungal agents in the future.

Restraints

Antifungal Resistance

  • Fungal pathogens are developing resistance to widely used antifungal agents and this has resulted in an epidemic of antifungal resistance that is rendering antifungal agents useless in most cases. This antifungal resistance could hurt market growth in the future.

Limited Spectrum

  • Antifungal agent for one infection might not work for another and this is why most antifungal agents have a limited spectrum of fungal infections that they can tackle. This limited spectrum of action is what will impede antifungal agents market development across the forecast period and beyond.

Request Free Customization of this report to help us to meet your business objectives.

Antifungal Agents Market Competitive Landscape

Antifungal agent manufacturers should invest heavily in R&D of novel agents and drugs that can be used for a wide variety of fungal infections. Antifungal agent companies can collaborate and partner with each other to fast track the development and launch of novel products going forward.

Top Player’s Company Profiles

  • Asperqillus
  • Alternaria
  • Sun Pharmaceutical Industries Ltd.
  • Eli Lily Company
  • Pfizer
  • GlaxoSmithKline
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Bayer Healthcare
  • Glenmark
  • Novartis
  • Cosmo Pharmaceuticals NV
  • Sanofi-Aventis
  • Astellas Pharma
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co.
  • Kramer Laboratories
  • Abbott Laboratories
  • Enzon Pharmaceuticals
  • Gilead
  • Zydus Cadila Healthcare Ltd.

Recent Developments

  • In December 2023, Astellas Pharma, a leading name in the pharmaceutical business, announced that it had received approval from the United States Food and Drug Administration (FDA) for the use of an azole antifungal drug called CRESEMBA. The drug was approved for the treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) in pediatric patients.

Antifungal Agents Key Market Trends

  • Personalized Medicine: Antifungal agent vendors can collaborate and partner with personalized medicine companies to develop specialized treatments using antifungal agents for patients affected with different kinds of fungal infections. Antifungal agents companies can take advantage of advancements in different personalized medicine approaches to maximize their revenue generation.

Antifungal Agents Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, rising incidence of fungal infections and advancements in fungal drug development are key factors promoting the demand for antifungal agents. Antifungal resistance and limited spectrum of antifungal agents are estimated to be the key constraints for antifungal agents market growth across the forecast period and beyond. North America leads the global sales of antifungal agents owing to the presence of a developed healthcare infrastructure and rising fungal infection prevalence. Antifungal agents market players should collaborate and partner with personalized medicine developers to enhance their future market growth potential.

Report Metric Details
Market size value in 2022 USD 14.4 billion
Market size value in 2031 USD 20.5 billion
Growth Rate 4%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Drug Type
    • Echinocandins, Azoles, Ployenes, Allylamines, and Others
  • Therapeutic Indication
    • Aspergillosis, Dermatophytosis, Candidiasis, and Others
  • Application
    • Powders, Ointments, Drugs, and Pastes
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Asperqillus
  • Alternaria
  • Sun Pharmaceutical Industries Ltd.
  • Eli Lily Company
  • Pfizer
  • GlaxoSmithKline
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Bayer Healthcare
  • Glenmark
  • Novartis
  • Cosmo Pharmaceuticals NV
  • Sanofi-Aventis
  • Astellas Pharma
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co.
  • Kramer Laboratories
  • Abbott Laboratories
  • Enzon Pharmaceuticals
  • Gilead
  • Zydus Cadila Healthcare Ltd.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Antifungal Agents Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Antifungal Agents Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Antifungal Agents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antifungal Agents Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antifungal Agents Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Antifungal Agents Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Antifungal Agents Market size was valued at USD 14.4 billion in 2022 and is poised to grow from USD 14.98 billion in 2023 to USD 20.5 billion by 2031, growing at a CAGR of 4% in the forecast period (2024-2031).

Antifungal agent manufacturers should invest heavily in R&D of novel agents and drugs that can be used for a wide variety of fungal infections. Antifungal agent companies can collaborate and partner with each other to fast track the development and launch of novel products going forward. 'Asperqillus', 'Alternaria', 'Sun Pharmaceutical Industries Ltd.', 'Eli Lily Company', 'Pfizer', 'GlaxoSmithKline', 'Sumitomo Dainippon Pharma Co. Ltd.', 'Bayer Healthcare', 'Glenmark', 'Novartis', 'Cosmo Pharmaceuticals NV', 'Sanofi-Aventis', 'Astellas Pharma', 'Teva Pharmaceutical Industries Ltd.', 'Merck & Co.', 'Kramer Laboratories', 'Abbott Laboratories', 'Enzon Pharmaceuticals', 'Gilead', 'Zydus Cadila Healthcare Ltd.'

Widespread antibiotic resistance and growing incidence of infectious chronic diseases are key factors responsible for increasing fungal infections among patients, which in turn, is projected to boost antifungal agent demand outlook.

Personalized Medicine: Antifungal agent vendors can collaborate and partner with personalized medicine companies to develop specialized treatments using antifungal agents for patients affected with different kinds of fungal infections. Antifungal agents companies can take advantage of advancements in different personalized medicine approaches to maximize their revenue generation.

North America is estimated to account for a substantial share of the antifungal agents market owing to rising cases of fungal infections in this region. of a developed healthcare infrastructure and growing investments in the R&D of novel antifungal drugs and medications are also contributing to the dominance of this segment over the coming years. Increasing cases of antifungal resistance in this region will also boost market growth going forward. The United States is forecasted to spearhead the demand for antifungal agents in the long run.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35J2113

$5,300
BUY NOW GET FREE SAMPLE